The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
- Autores
- Ritacco, Viviana; Gonçalves Morgado, Marisa; García, Luis Fernando
- Año de publicación
- 2011
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Gonçalves Morgado, Marisa. Oswaldo Cruz Foundation (FIOCRUZ): Rio de Janeiro CEP; Brasil.
Fil: García, Luis Fernando. Grupo de Inmunología Celular e Inmunogenética (GICIG), Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellin; Colombia.
The work summarizes the results of a survey on human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) situation that was undertaken within the frame of the EC FP7 EucoNet project. Updated data on HIV infection, acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) in South America are presented as well as a state of the art regarding disease management and research activities in 10 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela. The average HIV prevalence is 0.5-<1.0% in most of the surveyed countries. Lower prevalences are found only in Bolivia, Chile and Ecuador. TB burden is unevenly distributed: Bolivia, Peru and Ecuador bear the highest disease loads (prevalence>140/100,000) whereas Chile, Uruguay and Venezuela bear the lowest (prevalence <25/100,000). HIV prevalence in incident TB cases ranges between 3% and 15% and mortality attributable to HIV/MTB co-infection is <1/100,000. All countries run national HIV/AIDS and TB control programmes with various degrees of efficiency and data availability/reliability. Diagnosis and treatment are free of charge and all countries adhere to diagnosis and treatment standards for TB and HIV/AIDS according to World Health Organisation guidelines. The main weaknesses are related to insufficient involvement of government administrations, poverty-related pockets of HIV/MTB co-infection in urban/suburban settings and lack of interaction between HIV/AIDS and TB programmes. Funds for HIV/AIDS are disproportionally higher than those allocated to TB and there is hardly any investment in the dual infection. Challenges and priority areas for research are presented, as stated by the South American experts at the EucoNet Workshop “Clinical and translational aspects of HIV/MTB co-infection” held in Stellenbosch, South Africa on July 23-24, 2009. - Fuente
- The Open Infectious Diseases Journal 2011; 5:81-88.
- Materia
-
Tuberculosis
VIH
Mycobacterium tuberculosis
América del Sur - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Repositorio
- Institución
- Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
- OAI Identificador
- oai:sgc.anlis.gob.ar:Publications/123456789/2232
Ver los metadatos del registro completo
id |
SGCANLIS_68c089072512157afc9d4312dc7b9e86 |
---|---|
oai_identifier_str |
oai:sgc.anlis.gob.ar:Publications/123456789/2232 |
network_acronym_str |
SGCANLIS |
repository_id_str |
a |
network_name_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
spelling |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South AmericaRitacco, VivianaGonçalves Morgado, MarisaGarcía, Luis FernandoTuberculosisVIHMycobacterium tuberculosisAmérica del SurFil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Gonçalves Morgado, Marisa. Oswaldo Cruz Foundation (FIOCRUZ): Rio de Janeiro CEP; Brasil.Fil: García, Luis Fernando. Grupo de Inmunología Celular e Inmunogenética (GICIG), Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellin; Colombia.The work summarizes the results of a survey on human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) situation that was undertaken within the frame of the EC FP7 EucoNet project. Updated data on HIV infection, acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) in South America are presented as well as a state of the art regarding disease management and research activities in 10 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela. The average HIV prevalence is 0.5-<1.0% in most of the surveyed countries. Lower prevalences are found only in Bolivia, Chile and Ecuador. TB burden is unevenly distributed: Bolivia, Peru and Ecuador bear the highest disease loads (prevalence>140/100,000) whereas Chile, Uruguay and Venezuela bear the lowest (prevalence <25/100,000). HIV prevalence in incident TB cases ranges between 3% and 15% and mortality attributable to HIV/MTB co-infection is <1/100,000. All countries run national HIV/AIDS and TB control programmes with various degrees of efficiency and data availability/reliability. Diagnosis and treatment are free of charge and all countries adhere to diagnosis and treatment standards for TB and HIV/AIDS according to World Health Organisation guidelines. The main weaknesses are related to insufficient involvement of government administrations, poverty-related pockets of HIV/MTB co-infection in urban/suburban settings and lack of interaction between HIV/AIDS and TB programmes. Funds for HIV/AIDS are disproportionally higher than those allocated to TB and there is hardly any investment in the dual infection. Challenges and priority areas for research are presented, as stated by the South American experts at the EucoNet Workshop “Clinical and translational aspects of HIV/MTB co-infection” held in Stellenbosch, South Africa on July 23-24, 2009.Bentham Open2011info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1874-2793https://benthamopen.com/ABSTRACT/TOIDJ-5-81http://sgc.anlis.gob.ar/handle/123456789/223210.2174/1874279301005010081The Open Infectious Diseases Journal 2011; 5:81-88.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISOpen Infectious Diseases Journalenginfo:eu-repo/semantics/openAccess2025-10-16T10:11:58Zoai:sgc.anlis.gob.ar:Publications/123456789/2232Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-10-16 10:11:58.473Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false |
dc.title.none.fl_str_mv |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
title |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
spellingShingle |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America Ritacco, Viviana Tuberculosis VIH Mycobacterium tuberculosis América del Sur |
title_short |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
title_full |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
title_fullStr |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
title_full_unstemmed |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
title_sort |
The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America |
dc.creator.none.fl_str_mv |
Ritacco, Viviana Gonçalves Morgado, Marisa García, Luis Fernando |
author |
Ritacco, Viviana |
author_facet |
Ritacco, Viviana Gonçalves Morgado, Marisa García, Luis Fernando |
author_role |
author |
author2 |
Gonçalves Morgado, Marisa García, Luis Fernando |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Tuberculosis VIH Mycobacterium tuberculosis América del Sur |
topic |
Tuberculosis VIH Mycobacterium tuberculosis América del Sur |
dc.description.none.fl_txt_mv |
Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. Fil: Gonçalves Morgado, Marisa. Oswaldo Cruz Foundation (FIOCRUZ): Rio de Janeiro CEP; Brasil. Fil: García, Luis Fernando. Grupo de Inmunología Celular e Inmunogenética (GICIG), Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellin; Colombia. The work summarizes the results of a survey on human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) situation that was undertaken within the frame of the EC FP7 EucoNet project. Updated data on HIV infection, acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) in South America are presented as well as a state of the art regarding disease management and research activities in 10 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela. The average HIV prevalence is 0.5-<1.0% in most of the surveyed countries. Lower prevalences are found only in Bolivia, Chile and Ecuador. TB burden is unevenly distributed: Bolivia, Peru and Ecuador bear the highest disease loads (prevalence>140/100,000) whereas Chile, Uruguay and Venezuela bear the lowest (prevalence <25/100,000). HIV prevalence in incident TB cases ranges between 3% and 15% and mortality attributable to HIV/MTB co-infection is <1/100,000. All countries run national HIV/AIDS and TB control programmes with various degrees of efficiency and data availability/reliability. Diagnosis and treatment are free of charge and all countries adhere to diagnosis and treatment standards for TB and HIV/AIDS according to World Health Organisation guidelines. The main weaknesses are related to insufficient involvement of government administrations, poverty-related pockets of HIV/MTB co-infection in urban/suburban settings and lack of interaction between HIV/AIDS and TB programmes. Funds for HIV/AIDS are disproportionally higher than those allocated to TB and there is hardly any investment in the dual infection. Challenges and priority areas for research are presented, as stated by the South American experts at the EucoNet Workshop “Clinical and translational aspects of HIV/MTB co-infection” held in Stellenbosch, South Africa on July 23-24, 2009. |
description |
Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011 |
dc.type.none.fl_str_mv |
info:ar-repo/semantics/articulo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
1874-2793 https://benthamopen.com/ABSTRACT/TOIDJ-5-81 http://sgc.anlis.gob.ar/handle/123456789/2232 10.2174/1874279301005010081 |
identifier_str_mv |
1874-2793 10.2174/1874279301005010081 |
url |
https://benthamopen.com/ABSTRACT/TOIDJ-5-81 http://sgc.anlis.gob.ar/handle/123456789/2232 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Open Infectious Diseases Journal |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Bentham Open |
publisher.none.fl_str_mv |
Bentham Open |
dc.source.none.fl_str_mv |
The Open Infectious Diseases Journal 2011; 5:81-88. reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" instacron:ANLIS |
reponame_str |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
collection |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN |
instname_str |
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
instacron_str |
ANLIS |
institution |
ANLIS |
repository.name.fl_str_mv |
Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán" |
repository.mail.fl_str_mv |
biblioteca@anlis.gov.ar |
_version_ |
1846146152609611776 |
score |
12.712165 |